Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

Items 31-40 of 78

Page
per page
  1. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  2. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  3. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL
  4. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: IGF-IR/IR/ALK inhibitor, ATP-competitive
      ≥26.65 mg/mL
  5. CH5424802
    A8393 CH5424802
    Target: ALK
    Summary: ALK inhibitor,potent and ATP-competitive
  6. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  7. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  8. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  9. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    Target: ErbB
    Summary: HER inhibitor
      ≥23.5 mg/mL
  10. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL

Items 31-40 of 78

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 5item
  2. Axl 4item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 6item
  7. c-RET 3item
  8. CSF-1R 2item
  9. EGFR 14item
  10. FAK 2item
  11. FGFR 4item
  12. FLT3 3item
  13. HER2 7item
  14. IGF1R 3item
  15. IRAK 1 item
  16. ITK 1 item
  17. LRRK2 4item
  18. PDGFR 5item
  19. Pyk2 1 item
  20. Spleen Tyrosine Kinase (Syk) 3item
  21. Src 7item
  22. Tie-2 2item
  23. Trk 2item
  24. VEGFR 15item
Specificity
  1. Selective 48item
Reversibility
  1. Reversible 5item
  2. Irreversible 4item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Raf 4item
  3. Aurora Kinases 2item
  4. CSF-1R 4item
  5. FLT3 5item
  6. Eph Receptors 1 item
  7. VEGFR 19item
  8. PDGFR 12item
  9. c-Kit 8item
  10. RET 1 item
  11. IRAK 1 item
  12. Bcr-Abl 5item
  13. FGFR 7item
  14. MET 3item
  15. Src 8item
  16. Trk Receptors 1 item
  17. STAT 1 item
  18. EGFR 13item
  19. FAK 2item
  20. JAK 2item
  21. Syk 3item
  22. ErbB 4item
  23. c-MET 4item
  24. PKC 1 item
  25. Lyn 1 item
  26. Pyk2 2item
  27. LRRK2 4item
  28. Insulin and Insulin-like Receptors 3item
  29. ALK 3item
  30. Angiotensin-Converting Enzymes (ACEs) 1 item
  31. Tie-2 1 item
  32. 5-Lipoxygenases 1 item
  33. Insulin Receptors 1 item
  34. IRG-1R 1 item
  35. ZAP-70 1 item
  36. c-RET 2item
  37. TAM kinase 1 item
  38. Fyn kinase 1 item
  39. Abl kinases 1 item
  40. AXL 1 item
  41. c-Fms tyrosine kinase 1 item
  42. insulin 1 item
  43. Lyn kinase 1 item
  44. Mer tyrosine kinase 1 item
  45. ErbB-2 1 item
  46. ITK 1 item
  47. DCLK2 1 item
  48. PTK 1 item
  49. Flk1 1 item
  50. YES 1 item
  51. Fyn 1 item
  52. enoyl-acyl-carrier protein reductase 1 item
  53. tropomyosin receptor kinase 1 item
  54. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 10item
  6. Cancer 52item
  7. Cervical Cancer 1 item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 7item
  12. Glioblastoma 3item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 3item
  15. Leukemia 2item
  16. Liver Cancer 2item
  17. Lung Cancer 2item
  18. Lung Carcinoma 1 item
  19. Lymphoma 4item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 6item
  25. Prostate Cancer 4item
  26. Renal Cancer 1 item
  27. Renal Cell Carcinoma 1 item
  28. Rheumatoid Arthritis 2item
  29. Thyroid Cancer 1 item